If this is the first time you are viewing this file, please choose 'Save As' from the 'File' menu
and resave this file as an Excel file type. This will greatly speed up future viewings of this file.
Short-Term Individual Animal Non Neoplastic Diagnosis
Study Information:
Chemical Name: | Diisopropylcarbodiimide |
CASRN: | ="693-13-0" |
Study Number: | C93020 |
Exposure Route: | SKIN APPLICATION |
TDMS Number: | 9302001 |
Sex: | Female |
Strain and Species: | F 344/N Rats |
Female Individual Animal Non Neoplastic Diagnoses
System |
Organ |
Site |
Treatment Group |
Number Examined |
Cage Number |
Animal Number |
Days on Study |
Lesion Found |
Lesion Name |
Lesion Qualifier |
Removal Reason |
Genital System |
Ovary |
|
10 MG/ML |
1 |
38 |
38 |
17 |
1 |
Cyst |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
10 MG/ML |
5 |
36 |
36 |
17 |
1 |
Hyperplasia |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
30 MG/ML |
5 |
42 |
42 |
17 |
1 |
Hyperplasia |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
30 MG/ML |
5 |
45 |
45 |
17 |
1 |
Hyperplasia |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
90 MG/ML |
5 |
46 |
46 |
5 |
1 |
Hyperplasia |
Mild |
Natural Death |
Integumentary System |
Skin |
Epidermis, SOA |
90 MG/ML |
5 |
47 |
47 |
5 |
1 |
Hyperplasia |
Mild |
Natural Death |
Integumentary System |
Skin |
Epidermis, SOA |
90 MG/ML |
5 |
48 |
48 |
5 |
1 |
Hyperplasia |
Mild |
Natural Death |
Integumentary System |
Skin |
Epidermis, SOA |
90 MG/ML |
5 |
49 |
49 |
5 |
1 |
Hyperplasia |
Minimal |
Natural Death |
Integumentary System |
Skin |
Epidermis, SOA |
90 MG/ML |
5 |
50 |
50 |
5 |
1 |
Hyperplasia |
Mild |
Natural Death |
Integumentary System |
Skin |
SOA |
Vehicle Control |
5 |
33 |
33 |
17 |
1 |
Hyperkeratosis |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
10 MG/ML |
5 |
36 |
36 |
17 |
1 |
Hyperkeratosis |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
10 MG/ML |
5 |
38 |
38 |
17 |
1 |
Hyperkeratosis |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
10 MG/ML |
5 |
39 |
39 |
17 |
1 |
Hyperkeratosis |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
10 MG/ML |
5 |
40 |
40 |
17 |
1 |
Hyperkeratosis |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
30 MG/ML |
5 |
41 |
41 |
17 |
1 |
Hyperkeratosis |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
30 MG/ML |
5 |
42 |
42 |
17 |
1 |
Hyperkeratosis |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
30 MG/ML |
5 |
43 |
43 |
17 |
1 |
Hyperkeratosis |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
30 MG/ML |
5 |
44 |
44 |
17 |
1 |
Hyperkeratosis |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
30 MG/ML |
5 |
45 |
45 |
17 |
1 |
Hyperkeratosis |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
90 MG/ML |
5 |
46 |
46 |
5 |
1 |
Hyperkeratosis |
Minimal |
Natural Death |
Integumentary System |
Skin |
SOA |
90 MG/ML |
5 |
48 |
48 |
5 |
1 |
Hyperkeratosis |
Minimal |
Natural Death |
Integumentary System |
Skin |
SOA |
90 MG/ML |
5 |
49 |
49 |
5 |
1 |
Hyperkeratosis |
Minimal |
Natural Death |
Integumentary System |
Skin |
SOA |
90 MG/ML |
5 |
50 |
50 |
5 |
1 |
Hyperkeratosis |
Minimal |
Natural Death |